Infectious Disease, Outbreaks and Communicable-Disease Control in Custody

Scope and warning#

This page addresses communicable disease in California county jails and state prisons: screening and diagnosis, isolation and housing, treatment and continuity, outbreak response, reporting and release planning, testing of prisoners after staff exposure, confidentiality, and disability discrimination based on infection. It addresses tuberculosis, HIV, hepatitis B and C, and respiratory epidemics such as COVID-19 as examples; other infections (methicillin-resistant staphylococcal infections, sexually transmitted infections, scabies, foodborne illness) follow the same framework. It does not address vaccination mandates for staff, employment claims of correctional health workers who are exposed (Roadmaps 012–028; 128), or immigration detention except where a decision on immigration detention is cited for its reasoning. Clinical descriptions are general orientation only; diagnosis, isolation criteria and treatment standards are matters for qualified experts (Roadmap 074). Nothing here states that any facility, county, contractor or clinician failed to control or treat any disease.

The factual situation this roadmap addresses#

A generic hypothetical. A 52-year-old man held pretrial in a county jail tells the intake nurse that he has HIV infection controlled on antiretroviral medication, and his medications are recorded. He is housed in a crowded dormitory. Over three weeks he submits sick-call requests describing a cough, fevers, night sweats and weight loss; he is given cough medicine and returned to the dormitory, and no chest radiograph, sputum test or isolation is ordered. During this period a housing officer, who learned his diagnosis from a medication-pass conversation, refers to it in front of other detainees. In the fourth week he is sent to a hospital, where he is diagnosed with active pulmonary tuberculosis and placed in airborne isolation. A contact investigation follows; several dormitory residents are found to have newly positive tuberculosis tests. Two weeks after his return to the jail on treatment, the criminal case is resolved and he is released on short notice; the medical record does not show that the local health officer was notified before release or that a treatment plan accompanied him. Health care at the jail is delivered under a county contract with a private company.

Governing law#

The constitutional framework: present illness and future risk

For a sentenced prisoner, the Eighth Amendment forbids deliberate indifference to serious medical needs (Estelle v. Gamble, AR-0961-C02) and to conditions posing a substantial risk of serious harm (Farmer v. Brennan, AR-0961-C03). For a pretrial detainee in the Ninth Circuit, medical-care and conditions claims are judged under the Fourteenth Amendment's objective standard (Gordon v. County of Orange, AR-0961-C01; Castro v. County of Los Angeles, AR-C29; Roadmap 042). An infected person's claim that his infection was not diagnosed or treated is a medical-care claim under these standards. (Grade: Settled.)

Helling supplies the rule for people who are exposed but not yet sick. The Court held that a prisoner may state a claim based on exposure to a condition "sure or very likely to cause serious illness and needless suffering," and set out a two-part inquiry. Objectively, the inquiry "requires more than a scientific and statistical inquiry into the seriousness of the potential harm"; the prisoner "must show that the risk of which he complains is not one that today's society chooses to tolerate." Subjectively, deliberate indifference "should be determined in light of the prison authorities' current attitudes and conduct." Helling involved secondhand tobacco smoke; its reasoning, and its citation of earlier decisions about the mingling of inmates with serious contagious diseases, are the foundation of exposure claims in infectious-disease cases. For a pretrial detainee, the objective standard of Castro and Gordon replaces the subjective component. (Grade: Settled (Helling); Settled in the Ninth Circuit (objective standard for detainees).)

Outbreaks and population-level claims

Outbreak litigation tests the government's response to a known, present risk across a population. The Ninth Circuit's COVID-19 decision in Roman v. Wolf, 977 F.3d 935 (9th Cir. 2020) (per curiam), involved civil immigration detainees rather than jail detainees, but its reasoning on conditions is instructive for jails. The court held that the district court "did not abuse its discretion by issuing some form of preliminary injunctive relief," agreeing that the government "likely failed to meet its constitutional duty to provide reasonably safe conditions to Plaintiffs." It described measures a court "may require" if needed to avoid unreasonable risk, including "a reduction in the population to a level that would allow for six-foot social distancing" and "imposing a temporary moratorium" on new admissions, and it vacated the provisions "ordering specific reductions in the detainee population" because "those circumstances have changed dramatically" by the time of the appeal. The lesson is twofold: constitutional duties apply to the population-level response to an epidemic, and injunctive relief is tied to current conditions and must be updated as they change. Numerous COVID-19-era class actions concerning California jails and prisons were litigated in 2020–2022; they are not described here because none was opened for this page (description level only). (Grade: Majority/likely (Roman is a published Ninth Circuit per curiam reviewing a preliminary injunction for civil immigration detainees; its application to jails is an analytical inference); Documented report (other COVID-19 litigation, not opened).)

Damages claims arising from an outbreak face two additional problems: proving that a particular person's infection was caused by a particular failure (Roadmap 075), and identifying the decision-maker whose response was objectively unreasonable or deliberately indifferent rather than a reasonable choice among imperfect options in rapidly changing conditions. Population-level relief is typically injunctive and subject to the PLRA's limits on prospective relief in prisoner cases (18 U.S.C. § 3626, not opened; Roadmap 081). (Grade: Analytical inference.)

Treatment decisions, prioritization and cost: hepatitis C

Hepatitis C litigation illustrates the boundary between rationing and indifference. Direct-acting antiviral medications cure most infections but are expensive, and correctional systems may adopt prioritization schemes based on the degree of liver fibrosis, as Florida's did in Hoffer. The Eleventh Circuit held, in Hoffer v. Secretary, Florida Department of Corrections, 973 F.3d 1263 (11th Cir. 2020), that a plan of monitoring inmates with minimal fibrosis (F0–F1) and treating those who "either (1) have an exacerbating illness, such as HIV, (2) exhibit signs of rapid fibrosis progression, or (3) advance to F2" was not "so reckless or conscience-shocking as to constitute deliberate indifference," reasoning that "the Eighth Amendment does not prohibit prison officials from considering cost," though cost "can never be an absolute defense to what the Constitution otherwise requires." That is out-of-circuit authority under the subjective Eighth Amendment standard. In the Ninth Circuit, Colwell's condemnation of categorical, policy-based denial of medically indicated treatment (AR-052-C01) and Snow's recognition that a jury may find a cost motive (AR-052-C02) frame the opposing argument; the result will depend on whether the scheme is a clinically defensible prioritization with monitoring and exceptions, or a categorical denial. Medication continuity for people who arrive on antiretroviral or hepatitis treatment is addressed in Roadmap 056. (Grade: Persuasive (Hoffer); Unsettled in the Ninth Circuit (application to HCV prioritization).)

Title 15: the communicable-disease plan and related standards

Title 15's local detention facility minimum standards are the relevant baseline for a California county jail; do not import them without qualification into CDCR state prisons or federal detention. Section 1206.5 remains a relevant reproduced provision, but the BSCC official Adult Title 15 publication effective April 1, 2025 was identified and its retrieval failed (HTTP 502); the 2023 amendment date alone does not establish currency of every surrounding provision. (Source: S18, S21; official version not authenticated.)

• The communicable-disease plan. Section 1206.5, "Management of Communicable Diseases in a Custody Setting," requires that the "responsible physician, in conjunction with the facility administrator and the county health officer," develop a plan to "address the identification, treatment, control and follow-up management" of tuberculosis and other communicable diseases, covering intake screening, symptom identification, medical referral, in-custody treatment and coordination with public health officials for community follow-up. The health authority's written policies must address, among other things, "the types of communicable diseases to be reported" and "the persons who shall receive the medical reports," confidentiality, housing considerations, and "reporting and appropriate action upon the possible exposure of custody staff to a communicable disease." The section cites Penal Code §§ 6030, 7501 and 7552 as reference.
• The health-care procedures manual. Section 1206 requires written policies, reviewed at least every two years, covering "management of incarcerated persons suspected of or confirmed to have communicable diseases" (§ 1206(i)), "patient confidentiality and its exceptions" (§ 1206(m)), and the transfer of health information including tuberculosis notices under Health & Safety Code §§ 121361 and 121362 (§ 1206(n)) (AR-069-S02).
• Intake screening. The receiving screening must include "communicable diseases" (§ 1207; AR-068-S04).

These are minimum standards enforced through the Board of State and Community Corrections inspection process and the health officer's inspection; they are evidence of the expected system, not themselves a private cause of action (Roadmap 088). (Grade: Settled — regulatory text (reproduction host); Analytical inference — evidentiary use.)

Public-health law: reporting, the health officer, and release notice

Reporting, version control and outbreaks. Title 17 § 2500(b) assigns health-care-provider case/suspected-case reporting by condition; § 2500(c) separately places procedural responsibility on an administrator of a facility or setting with multiple providers. The 2025 CDPH provider letter identifies COVID-19 hospitalizations only as the reportable individual COVID-19 condition, not every positive test as under the older 2022 reproduced text. A suspected outbreak has its own immediate telephone-reporting pathway; specific tuberculosis, acute HIV, hepatitis and other condition deadlines and method (telephone/electronic submission) must be read from the version effective on the incident date, especially across June 2025. Local health departments may use different accepted reporting mechanisms. CDPH's August 2025 HTML points to an updated June 2025 list; the official PDF and Barclays regulation were indexed but full access failed (HTTP 502/403), so exact current condition-specific timing is not represented here as authenticated. Build a condition-by-date matrix before alleging late or missing notice. (Grade: Official CDPH indexed guidance on narrowed COVID-19 category; page and regulation direct authentication unavailable. Sources: S01–S05, S17.)

The health officer's duty. "Each health officer knowing or having reason to believe that any case of the diseases made reportable by regulation of the department, or any other contagious, infectious or communicable disease exists, or has recently existed, within the territory under his or her jurisdiction, shall take measures as may be necessary to prevent the spread of the disease or occurrence of additional cases" (Health & Saf. Code § 120175). A county jail is within the county health officer's territory. (Grade: Settled — statutory text.)

Jail inspections after the 2025 statutory rewrite. Health and Safety Code § 101045 was repealed and added by SB 1132, effective January 1, 2025. Its current reproduced subsections distinguish (a) annual county and applicable city health-officer investigations of health and sanitary conditions, submission to the specified local and state recipients, and discretionary additional investigations including designated private detention facilities; (b) requested investigations by enumerated officials or BSCC, not more than twice annually; (c) minimum food, clothing, bedding and restaurant-sanitation checks; and (d) the cross-reference defining private detention facilities. The phrase health and sanitary conditions does not, standing alone, establish that a statutory report assessed every clinical-care lapse. A particular report's existence, contents, custodian, exemptions and disclosure status must be verified under the applicable CPRA rules rather than assumed. (Grade: Reproduced 2025 statutory text, unofficial; application of report findings case-specific. Source: S06.)

Active tuberculosis: separate release and transfer routes. Under Health and Safety Code § 121361, determine whether staff knew or had reasonable grounds to believe the person had active TB disease, and distinguish a hospital/health-facility discharge from a correctional release, transfer within the same correctional system, transfer between systems, and transfer across jurisdictions. Each route determines the required notification recipient and treatment-plan approval/receipt; for qualifying intersystem transfer the receiving institution's chief medical officer is an additional material recipient. Do not call every intrasystem move a prohibited transfer. The exception permitting the notification/plan within 24 hours after an event is conditioned on the statutory jeopardy rationale (health, safety or security), not mere administrative convenience or every short-notice release. Section 121362 requires pertinent current information, including verified address and agreed postrelease provider information where applicable. Inspect written treatment plan, transmission timestamps, actual recipient, reason for urgency and public-health collaboration before pleading noncompliance; violation alone does not automatically prove a private remedy or causation. (Grade: Statutory reproductions, not official California Legislature authentication. Sources: S07, S08, S20.)

Confidentiality and public-health disclosure. California's Confidentiality of Medical Information Act provides that a provider of health care, health care service plan or contractor "shall not disclose medical information" regarding a patient "without first obtaining an authorization, except as provided in subdivision (b) or (c)" (Civ. Code § 56.10(a)); subdivision (c) permits disclosure to public-health authorities "as permitted by state and federal law or regulation" for purposes including "preventing or controlling disease," and where "otherwise specifically authorized by law." Reporting to the health officer is therefore not a confidentiality breach; gossip by staff is a different matter (below). (Grade: Settled — statutory text.)

The public-health immunity

State public-health discretion is not all-purpose immunity. Government Code § 855.4(a) addresses qualifying discretionary decisions about disease control in the community and § 855.4(b) addresses due-care implementation of those decisions. Analyze the challenged act separately: health-officer policy, housing implementation, individual bedside diagnosis, and failure to perform a nondiscretionary duty are not categorically the same conduct. The provision concerns California-law liability, not an automatic defense to federal § 1983 constitutional claims. In Hampton v. State of California, 83 F.4th 754 (9th Cir. 2023), the court held on interlocutory appeal that asserted California state immunities were defenses from liability, not from suit, so their denial was not independently reviewable as a collateral order; it did not decide ultimate state-law immunity on the facts. Combine with §§ 844.6 and 845.6 only after identifying the defendant and legal claim (Roadmaps 077–079). (Grade: § 855.4 statutory reproduction; Hampton published Ninth Circuit procedural holding. Sources: S09, S10.)

Tuberculosis: screening, isolation and release#

The CDC's 2006 MMWR correctional tuberculosis recommendations remain an important historical and technical reference, but are not a substitute for current guidance. The CDC's December 10, 2024 correctional-facility TB webpage emphasizes entry assessment for active TB, airborne precautions and appropriate isolation, early treatment, contact investigation, public-health collaboration and comprehensive discharge planning; it links to older detailed recommendations rather than stating that every 2006 engineering passage has been withdrawn. Distinguish a symptom-based evaluation for possible active TB disease from IGRA/TST testing for TB infection; a positive infection test cannot establish whether active disease was present at intake, and a negative result early after exposure may require later retesting. The CDC's separate correctional-staff recommendations call for exposure-specific symptom screening and repeat infection testing 8–10 weeks after last exposure for initially negative staff and caution against blanket annual staff testing absent specified risks, while the CDC correctional TB overview uses broader annual-testing language for some populations; document the apparent guidance tension and ask an infection-control expert to identify the applicable staff category and current jurisdiction-specific protocol. Guidance informs expert analysis; it is not by itself a statutory private cause of action or proof of breach. (Sources: S11, S12, S23 and inherited 2006 guidance.)

Tuberculosis claims present separate theories: delayed recognition or treatment of active illness; exposure of another person to a recognizable infectious risk; and interruption of care on release. A clinician or epidemiologist must test competing explanations using symptom onset, imaging, microbiology, infection-test type and timing, travel/community exposure, documented contact tracing and, when available, genotyping/whole-genome sequencing. Latent TB infection is not equivalent to active contagious disease, and a conversion result alone does not date transmission with certainty; conversely, a positive baseline infection test does not rule out later active disease resulting from delayed medical care. Assess the limitations of early testing and repeat-testing intervals before estimating the probability that a facility exposure caused infection. Distinguish causation of initial acquisition from causation of additional injury due to delayed diagnosis. (Grade: Expert-dependent inference informed by CDC guidance. Sources: S11, S12, S23.)

HIV, hepatitis C and confidentiality#

Staff-exposure testing has procedural and privacy gates. Penal Code §§ 7500–7517 establish specified processes for occupational body-fluid exposure; § 7510 generally requires the incident report by the shift's end or, where impracticable, within two days, subject to the statute's good-cause waiver. A report is not itself consent for or an automatic command to test the subject. Under § 7511(a) the chief medical officer must decide within 24 hours after receipt whether to require HIV/hepatitis B/hepatitis C testing even where no request is made; under § 7511(b) a test may be ordered only upon a finding of significant transmission risk based on the relevant facts. Section 7517 guards procedure records' confidentiality. Maintain an occupational-exposure health response without bypassing protected records or supposing an employee's request settles the statutory threshold. Confirm the relevant category and designated recipient under § 7510, rather than generalizing jail procedures to every facility or incident. (Grade: Reproduced 2025 statutory provisions; official text not independently authenticated. Sources: S13–S15.)

**HIV test-result confidentiality, not every HIV reference. Health and Safety Code § 120980 addresses disclosure of a test result identifying the test subject, with distinctions among negligent, willful and malicious disclosure, statutory permissions/exemptions, available civil penalties, actual damages and misdemeanor provisions with their predicates. An employee's verbal reference to someone's asserted HIV status does not, without more evidence, establish a disclosure of an identifiable test result** under that specific statute. Trace the precise information, its origin, recipient, authorization, purpose, and applicable exception; analyze CMIA, contractual confidentiality and possible constitutional privacy theories independently, subject to their own actor and cause-of-action requirements. Obtain a claimant's authorized records only; do not circulate a third party's status to test the theory. (Grade: Reproduced § 120980; statutory-scope conclusion dependent on facts. Sources: S16, S24.)

HIV and disability. "Respondent's HIV infection is a physical impairment which substantially limits a major life activity, as the ADA defines it" (Bragdon v. Abbott, 524 U.S. 624 (1998)). Exclusion of a person with HIV or another infection from programs, work assignments or housing because of the infection is a Title II question (Roadmap 068), and any exclusion on safety grounds requires an individualized direct-threat assessment: "[t]he existence, or nonexistence, of a significant risk must be determined from the standpoint of the person who refuses the treatment or accommodation," and "the risk assessment must be based on medical or other objective evidence" (Bragdon); "individualized assessment, based on reasonable judgment that relies on current medical knowledge or on the best available objective evidence" (28 C.F.R. § 35.139(b), AR-068-R08). Isolation of a person with an airborne infectious disease during the infectious period is a recognized medical measure; exclusion of a person with a blood-borne infection from ordinary programs on that basis alone presents the direct-threat question. (Grade: Settled (Bragdon; regulation); Analytical inference (application).)

Applying the law to the hypothetical#

Hypothetical application, not an established incident: If the stipulated symptom chronology, HIV history and absence of timely testing were proved by authorized records, a Fourteenth Amendment detainee-care theory would require intentional relevant decisions, objectively unreasonable failure to take reasonable available measures, and actual causal injury under Gordon. Expert assessment should compare then-available symptoms, alternatives, contemporaneous guidelines, facility capacity, timing, records and reasonable differential diagnosis—not assume bad care solely from eventual TB diagnosis. State negligence, county liability and contractor responsibility follow distinct legal elements, public-entity claim requirements and relevant immunities, rather than automatic respondeat superior under § 1983. The county's § 855.4 theory demands an act-by-act public-health discretion analysis. (Sources: S09–S12; other underlying Gordon precedent inherited.)

Hypothetical exposure and release theories: A later positive IGRA/TST among dormitory contacts may support an exposure investigation but does not by itself establish where infection arose, when it developed, or whether the person has active TB. A Helling-type claim requires serious intolerable risk and the applicable defendant-specific prisoner/detainee standard; damages additionally require causation and injury. An officer's alleged comment about HIV status raises privacy/CMIA questions, but § 120980 specifically requires qualifying identifying test-result disclosure. An apparent missing release notification requires actual assessment of the § 121361 route, exception, recipient and documented delivery rather than treating a gap in one chart as proof no notice occurred. Proof must identify the respective county, contractor and clinician duties without inferring entity control or culpability from a brand. All these statements are conditional analyses of a fabricated example; no case-specific evidence was inspected. (Sources: S07, S08, S12, S16.)

A step-by-step approach#

1. Identify the infection, the dates of symptoms, diagnosis and treatment, and whether the person was infected before, during or after custody; obtain intake screening and baseline test results.
2. Separate the claim types: the infected person's care; exposure of others; confidentiality; release planning; disability exclusion.
3. Request the person's own medical record, including screening, sick-call slips, radiology, laboratory results and isolation orders (Health & Saf. Code § 123110; Roadmap 083).
4. Request inspection reports, public contract provisions and any legally disclosable aggregate outbreak material through the correct custodian, distinguishing § 101045 health inspections from BSCC inspections. Do not assume individual patient information or all health-department reports are freely releasable; apply CPRA exemptions, redaction and privacy protections (Roadmaps 087, 097–099; Gov. Code § 7920.000 et seq.).
5. Identify the facility's § 1206.5 plan and § 1206 procedures and the health-services contract's infection-control and reporting terms (Roadmaps 086, 088).
6. Exhaust the jail or prison grievance procedure while in custody (Roadmap 080).
7. Promptly request preservation, not unauthorized disclosure, of movement and housing logs, clinical encounters, diagnostic and isolation timestamps, appropriately scoped public-health notification receipts, ventilation records, outbreak response plans and video. Demand de-identification or a court protective order for other detained persons' test results (Roadmap 007).
8. Calendar with counsel the limitation sources for each claim family, including Government Claims Act presentation for any state-law claim against a public entity.
9. Retain infectious-disease and correctional-health experts early (Roadmaps 074, 075).

Elements of the claim#

Infected person's medical-care claim: as in Roadmaps 042 (detainees: intentional decision; substantial risk; failure to take reasonable available measures a reasonable official would have appreciated; causation) and 043 (prisoners: serious need; knowledge; disregard; harm).

Exposure claim (Helling): an objectively serious risk of serious illness that society does not tolerate; for prisoners, deliberate indifference in light of officials' current attitudes and conduct; for detainees, an objectively unreasonable failure to take reasonable available measures; causation and injury (for damages) or a continuing risk (for injunctive relief).

Entity (§ 1983): a policy, custom, practice or decision of the county or contractor that was the moving force (Monell, AR-0961-C04; Tsao, AR-0961-C08; Roadmap 047).

HIV disclosure (§ 120980): a disclosed identifying HIV test result, recipient, actual act, statutory actor and mental-state requirement, absence of exception, and the applicable threshold for civil penalty, damages or other remedy. A statement that a person has HIV is not automatically a disclosure of the test result; test separately under CMIA/other privacy law when supported. (Source: S16.)

Disability (Title II): as in Roadmap 068, with the direct-threat inquiry for safety-based exclusion.

Do not allege a fact unless you have a good-faith factual basis for it. In infectious-disease cases that applies with special force to allegations about where and from whom an infection was acquired, which require epidemiological support.

Potentially relevant defendants#

By role and function only: clinicians who assessed or failed to assess the symptoms; the health administrator responsible for the § 1206.5 plan and isolation capacity; custody officials who controlled housing, movement and population; any person who disclosed protected information; the private contractor entity that employed the clinicians and contracted for infection-control services (identified from the contract and records); the county, as the operator of the jail, a Monell defendant for its own policies, and a public entity under the Government Claims Act; and, for state prisoners, the state department (subject to Eleventh Amendment limits). The county health officer acts in a regulatory capacity, and claims against a health officer's discretionary public-health decisions face § 855.4. Liability is never inferred from branding (Roadmaps 003, 004, 101).

Administrative prerequisites#

PLRA exhaustion for people who are prisoners when they sue (42 U.S.C. § 1997e(a), AR-096-F04; Ross v. Blake, AR-0961-C09; Roadmap 080). Government Claims Act presentation for state-law damages claims against public entities and employees (Gov. Code §§ 905, 910, 911.2, 945.4; AR-S501, AR-131-S01, AR-096-S01, AR-096-S02), but not for § 1983 claims (Williams v. Horvath, AR-C08). Code Civ. Proc. § 364 notice for professional-negligence claims against health care providers (AR-096-S04). Bankruptcy gate: check Roadmaps 090/091 before suing any Wellpath debtor entity.

Limitation periods#

Roadmaps 008, 078 and 082 explain the interaction. No date is computed here.

Evidence and records to obtain#

Records key: H has lawfully; R statutory request; D discovery or subpoena only; P potentially privileged or private; K someone else must preserve but need not produce voluntarily; X must not access, copy or remove.

• The person's own intake screening, sick-call requests, vital signs, radiology and laboratory results, isolation orders, medication records and release documents — R (Health & Saf. Code § 123110, AR-S401; Roadmap 083).
• The person's own grievances and responses — H or R.
• Hospital and public-health clinic records for the person — R.
• The person's own public-health file (tuberculosis case management, contact-investigation notice to the person) — R from the health department where the law permits; otherwise D.
• County/city health-officer § 101045 reports and BSCC inspection reports — R, subject to custodian confirmation, CPRA exemptions, privilege and redaction; a general right of access does not apply to individually identifiable third-party public-health case data (Roadmaps 087, 097–099).
• The facility's § 1206.5 communicable-disease plan and § 1206 procedures, with version histories — D; county-adopted documents may be public records.
• The health-services contract's infection-control, isolation, reporting and discharge-planning terms — public record (Roadmaps 086, 087).
• Housing assignments, bed-movement logs, isolation-room logs, ventilation and maintenance records — D; K (preservation demand).
• Contact-investigation records and other detainees' test results — P (others' health information; reached only in de-identified or protected form through court-supervised discovery).
• Disease reports to the health officer under Title 17 § 2500 — D (and confidential public-health records; counsel question).
• Records of any § 7510 testing process — P (confidential under § 7517).
• Peer-review, quality and infection-control committee minutes — P (Evid. Code § 1157, AR-032-S04; Roadmap 085).
• Video of housing and medical areas — K.
• The jail's electronic health record, jail management system and any other person's chart — X. No one should access, copy or remove them outside lawful process.

Favorable and adverse facts#

Facts that tend to help: documented classic symptoms over time without diagnostic testing or isolation; a known risk factor (such as HIV infection) recorded at intake; housing of a symptomatic person in congregate settings; absence of a functioning isolation room or failure to use one; health officer inspection reports noting crowding or ventilation problems at the relevant time; a release without the § 121361 notice and plan; a communicable-disease plan that was not followed; disclosure of HIV status by staff to other detainees.

Facts that may defeat or narrow a theory: prompt evaluation and medically appropriate isolation based on contemporaneous findings; another plausible differential diagnosis; compatible testing windows or prior baseline infection; credible outside-custody transmission; properly documented § 121361 jeopardy-based postevent notice within the permitted period; authorized public-health disclosure distinguishable from unauthorized HIV-result disclosure; adequate and available grievance remedies not exhausted; and no provable causal injury. An intake positive IGRA/TST may indicate earlier TB infection, but does not prove active disease began before custody or disprove injury from delayed treatment; an early negative result can require 8–10 week follow-up. Do not weigh evidence without the clinical/exposure timeline. (Sources: S07, S08, S11, S12, S23.)

Likely defenses#

Adversarial defense cross-check (Roadmap 133): defendants may establish no recognizable risk, reasonable contemporaneous treatment, insufficient proof of acquisition or preventable injury, nonparticipation, no county/contractor policy moving force, applicable state-law immunity, available unexhausted remedies or no qualifying disclosure of an identifying HIV test result. A PREP Act defense needs covered countermeasure activity and the required causal nexus, not the mere historical existence of a COVID emergency: Hampton, 83 F.4th 754, rejected categorical immunity at the pleading stage for alleged failures and stale pretransfer testing not causally contributing to the injury, without deciding every possible future PREP defense. Hampton likewise rejected public-official qualified immunity on the pleaded Eighth Amendment exposure allegations under then-clearly-established law, not every conceivable outbreak factual scenario. Asserted Wellpath debtor-plan injunctions and corporate status remain unverified inherited leads until original court orders, schedules and entities are inspected; do not convert Roadmaps 090/091 into resolved namespace mappings. (Sources: S09, S10, S16, S22.)

The deep companions to Roadmap 133 for these defenses are Playbooks 141 (constitutional medical-care defenses) and 142 (Monell and corporate liability).

Causation#

Causation must distinguish acquisition from progression and additional injury. For initial infection, assess transmission opportunity against incubation/infection-test windows, baseline and repeat IGRA/TST timing, other environments, contact investigations, pathogen sequencing when available and sampling bias. A positive infection test at intake suggests infection may predate custody but does not establish whether active TB developed or worsened because later symptoms were neglected; an initially negative test followed by conversion increases the significance of documented exposure but does not automatically prove custody acquisition, particularly if testing occurred during the immunologic window. For delayed diagnosis/treatment, ask the independent question whether earlier clinical steps would have prevented serious deterioration. For release, prove which statutory notice route applied and whether interruption caused harm. Expert testimony should address alternative causes with appropriately qualified probabilities, not substitute association for individual causation. (Grade: Expert-dependent analytic framework, sources S11, S12, S23.)

Damages and remedies#

Remedies are theory-specific. Compensatory damages require an adequately proven injury and causal defendant conduct; survival/wrongful-death claims, professional-negligence limits and § 120980 remedies involve distinct state-law predicates. Federal § 1983 punitive damages require their own individual-defendant standard, and cannot be imposed on a municipality merely from a contractor's employee; City of Newport remains the relevant inherited reference. Prospective relief depends on a sufficiently continuing risk, standing and applicable PLRA limits. 42 U.S.C. § 1997e(e) restricts damages for mental/emotional injury without the required predicate injury while the person is a prisoner; exposure-only relief should not be equated to compensatory recovery for actual infection. An actual TB infection or illness may supply a physical injury, but the degree and causal relation remain proof questions. (Inherited remedies cases not fully re-citator-checked in this run.)

Discovery#

The core discovery targets are the communicable-disease plan and its implementation; isolation capacity and use; housing and movement data; ventilation and maintenance; the triage of the claimant's sick-call requests; the reports made to the health officer; contact-investigation records; release-planning records; staff training on infection control and confidentiality; and, in outbreak cases, the decision record of population management (who decided what, when, on what information). An entity deposition of the county and of the contractor on "the identification and isolation of persons with suspected tuberculosis," "the communicable-disease plan under Title 15 § 1206.5," and "discharge notification to the local health officer" is the efficient tool (Roadmaps 084, 038). Public-health records about others are confidential and are reached, if at all, in de-identified or protected form.

CFMG/Wellpath-specific relevance#

CFMG/Wellpath relevance is structural, not an allegation. In a county-contracted correctional health system, identify the actual county operator, health officer's independent powers, contractor named legal entity, facility-by-facility contracting parties, employment dates, infection-control delegation and custody-versus-clinician decisions from signed contracts, insurer records, payroll/employment evidence, corporate filings and policies. Records held by a public agency may contain protected health or security material and are not therefore automatically disclosable. Inherited references AR-B071/AR-B12 assert differences between California Forensic Medical Group, Inc. and Wellpath CFMG, Inc. bankruptcy status; no primary bankruptcy docket, court order, debtor schedule, California corporate charter or entity-specific payroll was authenticated in this review, so both the asserted debtor/nondebtor distinctions and any injunction scope remain open research leads, not established facts. Preserve the 079–099 and 100–124 namespace holds and do not treat Roadmap 090/091 omissions as resolved collisions. No claim about misconduct, transmission, disability, or privacy by any named entity is made here. (Source: S22; inherited, unverified.)

Primary authorities#

Related roadmaps#

003, 004, 007, 008, 040, 041, 042, 043, 044, 047, 051, 054, 056, 057, 059, 064, 065, 066, 068, 074, 075, 077, 078, 079, 080, 081, 082, 083, 084, 085, 086, 087, 088, 090, 091, 093, 096.2, 133. The 079–099 and 100–124 numbering ranges are held; these numbers are inherited pointers, not reconciled canonical target mappings.

Companion worksheet#

Worksheet 109 (custody, clinical, movement, referral, grievance and urgent-care records): symptom onset and each response; specific infection-test type, collection/result dates and test-window caveats; relevant exposure history and housing/airflow; clinical differential and diagnostic decisions; isolation and treatment timestamps; hospitalization; notified local public-health authority, method/receipt and effective reporting rule, and any § 121361 release/transfer route and genuine emergency exception. Worksheet 110 for contemporaneous plan, versions, training and custody/clinical responsibilities; Worksheet 111 for fatality where supported; Worksheet 114 for preservation and lawful access only. Worksheet 124 is an inherited unverified cross-reference within the held 100–124 namespace, not a newly authenticated disability-workbook assignment. Prefer de-identified public-health aggregate data and protective orders for others' charts.

What this page cannot do#

This working chapter cannot determine which person contracted infection in custody, when/where infection originated, whether a clinician or facility violated a duty, whether reporting was legally required under the version applicable to a given date, or whether a statutory exception/immunity defeats a specific claim. It supplies no clinical opinion, no verified corporate or debtor status, no calculated filing date and no individual-specific public-health facts. Official California legislation and regulatory authentication, complete opinion citator history, independent contextual privacy review and human/counsel clearance remain separate unpassed gates; the private candidate is not a publication authorization.